Market Samachar
Home  ›  GLOBAL
Language Englishతెలుగుहिन्दीதமிழ்मराठीবাংলাಕನ್ನಡ
STAT · GLOBAL ·

Revolution Medicines starts shipping experimental pancreatic cancer drug - statnews.com

As reported by STAT
CEO Mark Goldsmith says Revolution Medicines will submit pancreatic cancer drug daraxonrasib for FDA approval soon.
▸ MARKET SAMACHAR VIEW
NEUTRAL
Read full article on STAT ↗

Market Samachar is a news aggregator. This article was originally published by STAT. Tap the button above to read the full story on their site.

🔥 Hot Now
Top stories across markets in the last hour

More from Market Samachar